Video Experimental Relacionado
Updated: Jan 24, 2026
11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
18.8K
Hepatitis viral y embarazo
Imane Ben M'Barek1, Jeanne Sibiude2, Élise Bouthry3
1Université aris Cité, ervice de ynécologieobstétrique, Beaujon, AP-HP, FETUS URP 7328, Clichy, France.
La Revue du praticien
|January 23, 2026
Resumen
La hepatitis viral en el embarazo presenta riesgos variados. El manejo de la Hepatitis B incluye detección y antivirales para prevenir la transmisión de madre a hijo, mientras que otros tipos como la Hepatitis E plantean graves riesgos.
Área de la Ciencia:
- Hepatología; Obstetricia; Enfermedades Infecciosas
Sus antecedentes:
- La hepatitis viral abarca varios virus distintos (A, B, C, D, E) con diferentes vías de transmisión e impactos clínicos.; El embarazo puede alterar el curso de la hepatitis viral, aumentando los riesgos tanto para la madre como para el feto.; Es crucial comprender los riesgos específicos asociados con cada tipo de hepatitis durante el embarazo para un manejo eficaz.
Objetivo del estudio:
- Revisar el impacto de los diferentes tipos de hepatitis viral en los resultados del embarazo.; Esbozar los riesgos de complicaciones obstétricas y transmisión vertical para cada virus de la hepatitis.; Resumir las estrategias de manejo actuales, incluida la detección y el tratamiento, para la hepatitis viral durante el embarazo.
Principales métodos:
- Revisión de la literatura sobre hepatitis viral en el embarazo.; Análisis de las vías de transmisión, las complicaciones obstétricas y los riesgos de transmisión vertical para la Hepatitis A, B, C, D y E.; Resumen de las guías de manejo, incluida la detección prenatal y las terapias antivirales.
Principales resultados:
- Hepatitis A: Generalmente leve, pero puede aumentar el riesgo de complicaciones obstétricas.; Hepatitis B: La más común, riesgo significativo de transmisión de madre a hijo, se maneja con detección y antivirales.; Hepatitis C: Principalmente transmitida por la sangre, se discuten las implicaciones para el embarazo.; Hepatitis D: Sobreinfecta la Hepatitis B, opciones de tratamiento limitadas durante el embarazo.; Hepatitis E: Grave en el tercer trimestre, riesgo de hepatitis fulminante, rara transmisión de madre a hijo.; En general, la transmisión de madre a hijo es rara y la lactancia materna es generalmente permitida.
Conclusiones:
- La presentación clínica y los riesgos de la hepatitis viral durante el embarazo son específicos del tipo.; El manejo proactivo, incluida la detección y las terapias dirigidas (especialmente para la Hepatitis B), es esencial para mitigar los riesgos.; Puede ser necesaria más investigación para el manejo de la Hepatitis D en poblaciones embarazadas.
Videos de Conceptos Relacionados
00:57Viral Recombination
25.0K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.0K
00:56Viral Structure
74.1K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
74.1K
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
01:21Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
00:36Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K